Lifeline Therapeutics Names Jim Krejci to Board of Directors; Company Welcomes Distinguished Business and Community Service Leader.

DENVER -- Lifeline Therapeutics, Inc. (OTCBB:LFLT), a publicly-traded health and nutrition company dedicated to better antioxidant therapies, announced today the appointment of Mr. Jim Krejci to its Board of Directors.

Mr. Krejci brings a wealth of healthcare and business leadership experience to the LFLT Board. His medical industry experience includes leadership at the 3M Company and General Electric Diagnostic Imaging Division, and culminated as Division President of Becton Dickinson Labware, with responsibility for over 800 employees.

Mr. Krejci worked in the private sector for over 30 years and managed high-tech and telecommunication firms, including the Mind Extension University, Jones Lightwave, Jones Futurex, Galactic Radio and other companies for Jones International, Ltd. and Jones Intercable, Inc. He has also been the CEO of a number of other high-tech start-ups in the Denver area and worked in the international sector as President, International Division, for International Gaming Technologies.

Mr. Krejci also brings a stellar community service background to the LFLT Board. He has served on the Board of Directors for Goodwill Industries of Denver, Denver Scores, and the American Diabetes Association (ADA) of Denver. He subsequently was appointed as the Executive Director of the New Mexico ADA, and presently serves as the Executive Director of the Epilepsy Foundation of Colorado.

Bill Driscoll, President & CEO of LFLT said, "Lifeline Therapeutics is a company dedicated to making a difference in our world through breakthrough antioxidant technologies as well as proactive humanitarian involvements. Mr. Krejci brings vital healthcare and community service leadership skills that will further position LFLT as a company with significant global impact."

Mr. Krejci also teaches Marketing Management, Principals of Leadership, Marketing Research and Management Theory and Practice at the University of Phoenix Online Graduate School of Business. He received a B.S. in Chemical Engineering and an MBA in Marketing from the University of Wisconsin with the distinction of graduating first in the MBA class.

ABOUT LIFELINE THERAPEUTICS

Lifeline Therapeutics, Inc. is a publicly-traded company (OTCBB:LFLT) based in Denver, Colorado, that is dedicated to the manufacture, marketing and distribution of therapies that promote "healthy life expectancy." The Company is initially focusing exclusively on unique antioxidant products under its Protandim brand and in the future will develop an array of product candidates for nutraceutical, pharmaceutical and cosmeceutical applications.

Except for historical information contained herein, this document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and applicable common law. These statements involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Further, the Company operates in industries where securities values may be volatile and may be influenced by regulatory and other factors beyond the Company's control. Other important factors that the Company believes might cause such differences include the Company's limited cash flow and the rapid development of technology, lack of liquidity for the Company's common stock, working capital shortages, the length of time for scientific advances to reach the market (if they ever reach the market), among other risks. In assessing forward-looking statements contained herein, readers are urged to carefully read all cautionary statements contained in the Company's filings with the Securities and Exchange Commission.